FDA Inspection 1022670 — E-Liquid Therapeutics, Inc.
The FDA completed an inspection of E-Liquid Therapeutics, Inc. on August 1, 2017 in Fremont, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Tobacco.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 1, 2017
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Project Area
- Tobacco Post-Market Activities
- Location
- Fremont, CA (United States)